FDAnews
www.fdanews.com/articles/116877-endosense-receives-ce-marking-for-ablation-catheter

Endosense Receives CE Marking for Ablation Catheter

May 6, 2009
Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received the CE mark for its TactiCath system.
CNBC